Preferred Label : Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination;
MeSH definition : Inhibitor or Reverse Transcriptases or of RNA-dIrected DNA polymerase.; Inhibitor of reverse transcriptases or of RNA-directed DNA polymerases.;
MeSH hyponym : atripla;
Is substance : O;
Origin ID : D000068257;
UMLS CUI : C2928676;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
See also
Semantic type(s)
UMLS correspondences (same concept)
Inhibitor or Reverse Transcriptases or of RNA-dIrected DNA polymerase.
Inhibitor of reverse transcriptases or of RNA-directed DNA polymerases.
https://www.has-sante.fr/jcms/p_3083824/fr/atripla
2019
true
France
French
guidelines for drug use
hiv infections
human immunodeficiency virus i infection
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
efavirenz
anti-hiv agents
reverse transcriptase inhibitors
insurance, health, reimbursement
tablets
administration, oral
adult
HIV-1
treatment outcome
emtricitabine, tenofovir disoproxil and efavirenz
evaluation of the transparency committee
benzoxazines
---
https://www.ema.europa.eu/medicines/human/EPAR/efavirenzemtricitabinetenofovir-disoproxil-krka
2018
false
United Kingdom
English
French
syndication feed
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
efavirenz
drugs, generic
Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal
product form)
europe
anti-hiv agents
acquired immunodeficiency syndrome
reverse transcriptase inhibitors
anti-hiv agents
drug combinations
hiv infections
administration, oral
treatment outcome
drug evaluation
reverse transcriptase inhibitors
HIV-1
adult
drug approval
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
emtricitabine, tenofovir disoproxil and efavirenz
package leaflet
drug evaluation
summary of product characteristics
benzoxazines
---
https://www.ema.europa.eu/medicines/human/EPAR/efavirenzemtricitabinetenofovir-disoproxil-zentiva
2017
false
United Kingdom
English
French
syndication feed
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
drugs, generic
anti-hiv agents
acquired immunodeficiency syndrome
reverse transcriptase inhibitors
anti-hiv agents
drug combinations
hiv infections
administration, oral
treatment outcome
reverse transcriptase inhibitors
HIV-1
adult
drug approval
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
emtricitabine, tenofovir disoproxil and efavirenz
package leaflet
drug evaluation
summary of product characteristics
---
https://www.ema.europa.eu/medicines/human/EPAR/efavirenzemtricitabinetenofovir-disoproxil-mylan
2017
false
United Kingdom
English
French
syndication feed
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
efavirenz
drugs, generic
human immunodeficiency virus i infection
europe
anti-hiv agents
acquired immunodeficiency syndrome
reverse transcriptase inhibitors
anti-hiv agents
drug combinations
hiv infections
administration, oral
treatment outcome
reverse transcriptase inhibitors
HIV-1
adult
drug approval
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
emtricitabine, tenofovir disoproxil and efavirenz
package leaflet
drug evaluation
summary of product characteristics
benzoxazines
---
https://www.ema.europa.eu/medicines/human/EPAR/Atripla
2012
false
United Kingdom
English
French
syndication feed
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
efavirenz
anti-hiv agents
acquired immunodeficiency syndrome
reverse transcriptase inhibitors
anti-hiv agents
drug combinations
hiv infections
tablets
administration, oral
treatment outcome
drug evaluation
reverse transcriptase inhibitors
HIV-1
adult
drug approval
drug labeling
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
emtricitabine, tenofovir disoproxil and efavirenz
package leaflet
drug evaluation
summary of product characteristics
benzoxazines
---
http://www.has-sante.fr/portail/jcms/c_743976/atripla-ct-6045
http://www.has-sante.fr/portail/jcms/c_743975/atripla
2009
false
France
French
guidelines for drug use
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
efavirenz
drug combinations
anti-hiv agents
reverse transcriptase inhibitors
insurance, health, reimbursement
tablets
administration, oral
adult
HIV-1
treatment outcome
emtricitabine, tenofovir disoproxil and efavirenz
evaluation of the transparency committee
benzoxazines
---
http://www.meddispar.fr/medicaments/3830699
2009
false
France
French
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
efavirenz
drug prescriptions
legislation, drug
administration, oral
tablets
emtricitabine, tenofovir disoproxil and efavirenz
drug information
benzoxazines
---
https://cadth.ca/sites/default/files/cdr/complete/cdr_complete_Atripla_April-17-2008-Fr.pdf
2008
false
Canada
French
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
efavirenz
anti-hiv agents
adult
emtricitabine, tenofovir disoproxil and efavirenz
reverse transcriptase inhibitors
drug evaluation
benzoxazines
---